PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medical Scientist Training Program (MD-PhD), Yale School of Medicine, New Haven, CT, USA; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520-8066, USA.\', \'Department of Chemistry, Yale University, New Haven, CT 06520-8107, USA.\', \'Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520-8066, USA.\', \'Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520-8066, USA; Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, CT 06520-8066, USA. Electronic address: karen.anderson@yale.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0969-2126(21)00206-910.1016/j.str.2021.06.002
?:hasPublicationType
?:journal
  • Structure (London, England : 1993)
is ?:pmid of
?:pmid
?:pmid
  • 34161756
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34161756>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34161756>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all